NURO Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (15 Apr 2024 @ 16:00):

Stats
Today's Volume	7 399.00
Average Volume	45 491.00
Market Cap	6.99M
EPS	$0 ( 2024-02-22 )
Next earnings date	( $0 ) 2024-05-01
Last Dividend	$1 728.00 ( 2007-03-28 )
Next Dividend	$0 ( N/A )
P/E	-0.560
ATR14	$0.0190 (0.54%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Higgins Thomas T	Buy	469	Common Stock
2024-04-01	Higgins Thomas T	Sell	74	Common Stock
2024-04-01	Higgins Thomas T	Sell	469	Restricted Stock Unit
2024-04-01	Gozani Shai	Buy	625	Common Stock
2024-04-01	Gozani Shai	Sell	77	Common Stock

INSIDER POWER
51.70
Last 98 transactions
Buy: 1 081 620 \| Sell: 254 579

NeuroMetrix Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

NeuroMetrix Inc Financials

Annual	2023
Revenue:	$5.90M
Gross Profit:	$3.95M (66.89 %)
EPS:	$-6.27

Q4	2023
Revenue:	$1.32M
Gross Profit:	$847 974 (64.35 %)
EPS:	$-1.080

Q3	2023
Revenue:	$1.20M
Gross Profit:	$781 782 (64.98 %)
EPS:	$-1.660

Q2	2023
Revenue:	$1.66M
Gross Profit:	$1.12M (67.60 %)
EPS:	$-1.560

Financial Reports:

No articles found.

NeuroMetrix Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

NeuroMetrix Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$1 728.00	2007-03-28
Last Dividend	$1 728.00	2007-03-28
Next Dividend	$0	N/A
Payout Date	2007-04-13
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$1 728.00	--
Avg. Dividend % Per Year	0.00%	--
Score	0.01	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-04-16)

$0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

0.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2007	$1.000	0.00%
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-1.083	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.298	1.200	-9.95	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.307	1.500	-4.52	-6.78	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	16.81	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	14.92	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	1.396	1.500	3.36	5.03	[0.2 - 2]
debtRatioTTM	0.0112	-1.500	9.81	-10.00	[0 - 0.6]
interestCoverageTTM	52.63	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	-3.99	2.00	-1.330	-2.66	[0 - 30]
freeCashFlowPerShareTTM	-4.11	2.00	-2.06	-4.11	[0 - 20]
debtEquityRatioTTM	0.0120	-1.500	9.95	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.669	1.000	2.19	2.19	[0.2 - 0.8]
operatingProfitMarginTTM	-1.212	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-25.26	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0.275	0.800	-1.497	-1.198	[0.5 - 2]
Total Score				-0.253

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-0.880	1.000	-0.190	0	[1 - 100]
returnOnEquityTTM	-0.307	2.50	-2.90	-6.78	[0.1 - 1.5]
freeCashFlowPerShareTTM	-4.11	2.00	-1.370	-4.11	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-3.99	2.00	-1.330	-2.66	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0300	1.500	-3.53	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-1.031	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-2.82

NeuroMetrix Inc

NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.